PMID- 29512923 OWN - NLM STAT- MEDLINE DCOM- 20191023 LR - 20210109 IS - 1582-4934 (Electronic) IS - 1582-1838 (Print) IS - 1582-1838 (Linking) VI - 22 IP - 5 DP - 2018 May TI - Modulation of the oxidative plasmatic state in gastroesophageal reflux disease with the addition of rich water molecular hydrogen: A new biological vision. PG - 2750-2759 LID - 10.1111/jcmm.13569 [doi] AB - Gastroesophageal reflux disease (GERD), a clinical condition characterized by reflux of gastroduodenal contents in the oesophagus, has proved to demonstrate a strong link between oxidative stress and the development of GERD. Proton pump inhibitors (PPIs) have been universally accepted as first-line therapy for management of GERD. The potential benefits of electrolysed reduced water (ERW), rich in molecular hydrogen, in improving symptoms and systemic oxidative stress associated with GERD was assessed. The study was performed on 84 GERD patients undergoing control treatment (PPI + tap water) or experimental treatment (PPI + ERW) for 3 months. These patients were subjected to the GERD-Health Related Quality of Life Questionnaire as well as derivatives reactive oxigen metabolites (d-ROMs) test, biological antioxidant potential (BAP) test, superoxide anion, nitric oxide and malondialdehyde assays, which were all performed as a proxy for the oxidative/nitrosative stress and the antioxidant potential status. Spearman's correlation coefficient was used to evaluate the correlation between scores and laboratory parameters. Overall results demonstrated that an optimal oxidative balance can be restored and GERD symptoms can be reduced rapidly via the integration of ERW in GERD patients. The relative variation of heartburn and regurgitation score was significantly correlated with laboratory parameters. Thus, in the selected patients, combination treatment with PPI and ERW improves the cellular redox state leading to the improvement of the quality of life as demonstrated by the correlation analysis between laboratory parameters and GERD symptoms. CI - (c) 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. FAU - Franceschelli, Sara AU - Franceschelli S AD - Department of Medicine and Science of Aging, University "G. D' Annunzio", Chieti, Italy. FAU - Gatta, Daniela Maria Pia AU - Gatta DMP AD - Department of Medicine and Science of Aging, University "G. D' Annunzio", Chieti, Italy. FAU - Pesce, Mirko AU - Pesce M AD - Department of Psychological, Health and Territorial Sciences, University "G. D' Annunzio", Chieti, Italy. FAU - Ferrone, Alessio AU - Ferrone A AD - Department of Medicine and Science of Aging, University "G. D' Annunzio", Chieti, Italy. FAU - Di Martino, Giuseppe AU - Di Martino G AD - Laboratory of Biostatistics, Department of Medical, Oral and Biotechnological Sciences, University "G. D' Annunzio", Chieti, Italy. FAU - Di Nicola, Marta AU - Di Nicola M AD - Laboratory of Biostatistics, Department of Medical, Oral and Biotechnological Sciences, University "G. D' Annunzio", Chieti, Italy. FAU - De Lutiis, Maria Anna AU - De Lutiis MA AD - Department of Medicine and Science of Aging, University "G. D' Annunzio", Chieti, Italy. FAU - Vitacolonna, Ester AU - Vitacolonna E AD - Department of Medicine and Science of Aging, University "G. D' Annunzio", Chieti, Italy. FAU - Patruno, Antonia AU - Patruno A AD - Department of Medicine and Science of Aging, University "G. D' Annunzio", Chieti, Italy. FAU - Grilli, Alfredo AU - Grilli A AD - Department of Psychological, Health and Territorial Sciences, University "G. D' Annunzio", Chieti, Italy. FAU - Felaco, Mario AU - Felaco M AD - Department of Medicine and Science of Aging, University "G. D' Annunzio", Chieti, Italy. FAU - Speranza, Lorenza AU - Speranza L AUID- ORCID: 0000-0002-7024-3257 AD - Department of Medicine and Science of Aging, University "G. D' Annunzio", Chieti, Italy. LA - eng PT - Clinical Trial PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180307 PL - England TA - J Cell Mol Med JT - Journal of cellular and molecular medicine JID - 101083777 RN - 0 (Antioxidants) RN - 0 (Proton Pump Inhibitors) RN - 059QF0KO0R (Water) RN - 7YNJ3PO35Z (Hydrogen) SB - IM MH - Adult MH - Aged MH - Antioxidants/metabolism MH - Gastroesophageal Reflux/*blood/*therapy MH - Humans MH - Hydrogen/*therapeutic use MH - Middle Aged MH - Oxidation-Reduction MH - Oxidative Stress/drug effects MH - Proton Pump Inhibitors/therapeutic use MH - Quality of Life MH - Water/*pharmacology MH - Young Adult PMC - PMC5908129 OTO - NOTNLM OT - electrolysed reduced water OT - gastroesophageal reflux disease OT - molecular hydrogen OT - nitric oxide OT - oxidative stress OT - proton pump inhibitors EDAT- 2018/03/08 06:00 MHDA- 2019/10/24 06:00 PMCR- 2018/05/01 CRDT- 2018/03/08 06:00 PHST- 2017/08/31 00:00 [received] PHST- 2017/12/22 00:00 [accepted] PHST- 2018/03/08 06:00 [pubmed] PHST- 2019/10/24 06:00 [medline] PHST- 2018/03/08 06:00 [entrez] PHST- 2018/05/01 00:00 [pmc-release] AID - JCMM13569 [pii] AID - 10.1111/jcmm.13569 [doi] PST - ppublish SO - J Cell Mol Med. 2018 May;22(5):2750-2759. doi: 10.1111/jcmm.13569. Epub 2018 Mar 7.